Figure 1.
(Key Figure): Microbial delivery roadmap. By following the roadmap developed for the controlled delivery of small-molecule therapeutics, including formulation for maintaining efficacy (through maintaining viability for microbes), selection of the proper materials for controlled release, and evaluation of the release, similar advantages to small-molecule delivery are expected for bacteria.
